.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Daiichi Sankyo
Baxter
Novartis
Boehringer Ingelheim
Deloitte
Johnson and Johnson
Chinese Patent Office
Teva
Queensland Health

Generated: December 14, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020702

« Back to Dashboard

NDA 020702 describes LIPITOR, which is a drug marketed by Pfizer and is included in one NDA. It is available from sixteen suppliers. There is one patent protecting this drug. Additional details are available on the LIPITOR profile page.

The generic ingredient in LIPITOR is atorvastatin calcium. There are sixty-one drug master file entries for this compound. Sixty-one suppliers are listed for this compound. Additional details are available on the atorvastatin calcium profile page.

Summary for 020702

Tradename:1
Applicant:1
Ingredient:1
Patents:1
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 020702

Medical Subject Heading (MeSH) Categories for 020702

Suppliers and Packaging for NDA: 020702

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LIPITOR atorvastatin calcium TABLET;ORAL 020702 NDA Parke-Davis Div of Pfizer Inc 0071-0155 0071-0155-10 1000 TABLET, FILM COATED in 1 BOTTLE (0071-0155-10)
LIPITOR atorvastatin calcium TABLET;ORAL 020702 NDA Parke-Davis Div of Pfizer Inc 0071-0155 0071-0155-23 90 TABLET, FILM COATED in 1 BOTTLE (0071-0155-23)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 10MG BASE
Approval Date:Dec 17, 1996TE:ABRLD:Yes
Regulatory Exclusivity Expiration:Jun 23, 2020
Regulatory Exclusivity Use:
Patent:► SubscribePatent Expiration:Jan 8, 2017Product Flag?Substance Flag?Delist Request?Y

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 20MG BASE
Approval Date:Dec 17, 1996TE:ABRLD:Yes
Regulatory Exclusivity Expiration:Jun 23, 2020
Regulatory Exclusivity Use:

Expired Orange Book Patents for NDA: 020702

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
PfizerLIPITORatorvastatin calciumTABLET;ORAL020702-002Dec 17, 1996► Subscribe► Subscribe
PfizerLIPITORatorvastatin calciumTABLET;ORAL020702-002Dec 17, 1996► Subscribe► Subscribe
PfizerLIPITORatorvastatin calciumTABLET;ORAL020702-001Dec 17, 1996► Subscribe► Subscribe
PfizerLIPITORatorvastatin calciumTABLET;ORAL020702-002Dec 17, 1996► Subscribe► Subscribe
PfizerLIPITORatorvastatin calciumTABLET;ORAL020702-003Dec 17, 1996► Subscribe► Subscribe
PfizerLIPITORatorvastatin calciumTABLET;ORAL020702-004Apr 7, 2000► Subscribe► Subscribe
PfizerLIPITORatorvastatin calciumTABLET;ORAL020702-002Dec 17, 1996► Subscribe► Subscribe
PfizerLIPITORatorvastatin calciumTABLET;ORAL020702-003Dec 17, 1996► Subscribe► Subscribe
PfizerLIPITORatorvastatin calciumTABLET;ORAL020702-004Apr 7, 2000► Subscribe► Subscribe
PfizerLIPITORatorvastatin calciumTABLET;ORAL020702-003Dec 17, 1996► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Mallinckrodt
Dow
Cantor Fitzgerald
Deloitte
Johnson and Johnson
Boehringer Ingelheim
Fuji
Julphar
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot